Relay Therapeutics Inc — Cash Flow (NASDAQ:RLAY) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities 102.49 M74.41 M229.49 M300.32 M249.11 M235.46 M 235.46 M Cash from investing activities 81.67 M479.51 M188.75 M257.63 M41.08 M192.8 M 192.8 M Cash from financing activities 426.51 M388.09 M289.91 M34.75 M270.15 M1.6 M — Free cash flow 100.56 M70.94 M220.43 M296.19 M247.09 M235.04 M 235.04 M

ニュース

Relay Therapeutics stock hits 52-week high at 9.64 USD

【決算速報】リレーセラピューティクス、売上高は予想を上回り、利益は予想を上回る結果に

Relay earnings beat by $0.09, revenue topped estimates

Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue Estimates

FDAのブレークスルー指定後、Relay Therapeuticsの決算に注目集まる

Relay Therapeutics earnings in spotlight after FDA breakthrough

BB Biotech 2025年度決算:利益660%急増も2026年は慎重見通し

Relay earnings in focus as FDA breakthrough fuels optimism

リレー・セラピューティクスの株価上昇、FDAが画期的治療薬指定を付与

Relay Therapeutics stock rises after FDA grants Breakthrough Therapy status

リレー社の乳がん薬、FDAからブレークスルー治療指定を獲得

FDA grants breakthrough therapy status to Relay’s breast cancer drug